The pool of HCV genotype 1 patients likely to be cured by peg-interferon and ribavirin remains to be quantified.
Andriulli, A., Di Marco, V., Margaglione, M., Ippolito, A., Fattovich, G., Smedile, A., et al. (2014). Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin. JOURNAL OF HEPATOLOGY, 60(1), 16-21 [10.1016/j.jhep.2013.07.040].
Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin
BARONE, MICHELE;ANGELICO, MARIO;
2014-01-01
Abstract
The pool of HCV genotype 1 patients likely to be cured by peg-interferon and ribavirin remains to be quantified.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavi.pdf
solo utenti autorizzati
Licenza:
Copyright dell'editore
Dimensione
194.39 kB
Formato
Adobe PDF
|
194.39 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.